ARLINGTON, Tenn.--(BUSINESS WIRE)--Wright Medical Group, Inc., a global orthopaedic medical device company, today announced that it has launched a new subsidiary, Wright Medical Australia Pty, LTD. The new entity will directly manage all of the Company’s extremity and biologics distribution for customers in Australia and New Zealand.
The creation of Wright Medical Australia is a pivotal move that will facilitate the Company’s long-term objective of launching a more comprehensive portfolio of products to address the needs of specific customer segments in that region. The development also aligns with Wright’s larger strategic vision of achieving focused selling through specialized distribution channels.
“Wright is extremely pleased to add the Wright Medical Australia entity to our global family of subsidiaries,” commented Karen L. Harris, Wright’s Sr. Vice President of International. “The new subsidiary will provide Wright with enhanced control over distribution activities, as well as the invaluable leadership of a highly experienced and focused team of professionals with specialized knowledge in the extremity field and successful histories in the Australian market.”
As a complement to its new direct extremity and biologics subsidiary, Wright has also enhanced its reconstructive joint sales capabilities in Australia through an agreement with distributor LSS Pty, Ltd. Wright’s reconstructive joint product distribution through this highly energized and dynamic organization will begin in Australia and New Zealand during the fourth quarter of 2009.
Wright Medical Group, Inc. is a global orthopaedic medical device company specializing in the design, manufacture and marketing of reconstructive joint devices and biologics. The Company has been in business for more than 50 years and markets its products in over 60 countries worldwide. For more information about Wright Medical, visit the company’s website at www.wmt.com.
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements made in this press release, other than statements of historical fact, are forward-looking statements. Forward-looking statements reflect management’s current knowledge, assumptions, beliefs, estimates, and expectations and express management’s current views of future performance, results, and trends and may be identified by their use of terms such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “will,” and other similar terms. The Company wishes to caution readers that actual results might differ materially from those described in the forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, including the factors discussed in the Company’s filings with the Securities and Exchange Commission (including the Company’s annual report on Form 10-K for the year ended December 31, 2008, under the heading, “Risk Factors”), which could cause the Company’s actual results to materially differ from those described in the forward-looking statements. Although the Company believes that the forward-looking statements are accurate, there can be no assurance that any forward-looking statement will prove to be accurate. A forward-looking statement should not be regarded as a representation by the Company that the results described therein will be achieved. The Company wishes to caution readers not to place undue reliance on any forward-looking statement. The forward-looking statements are made as of the date of this press release. The Company assumes no obligation to update any forward-looking statement after this date.
Contact:
Wright Medical Group, Inc. John K. Bakewell, 901-867-4527